Venturelab
close

Low-cost accurate molecular tests from point-of-care to home

Testmate Health SA

Swiss Startup - Testmate Health Profile Main Image
Incorporated
28.04.2020
Headquarters
Epalinges
Support

Testmate Health has microengineered the power of a PCR machine into a low-cost, single-use disposable, test that can detect any DNA or RNA sequence with immediate results from the point-of-care to at-home. Our technological platform has proven lab equivalent accuracy even in challenging samples like urine.

Our first product addresses the $14B sexual health & women's health market, with the first disposable urine test that can detect chlamydia & gonorrhoea in all genders. Built for automated high scaled manufacturing, low COGs & high usability, Testmate addresses the rising silent epidemic of sexually transmitted infections, in a product format & price point that is finally compatible with the public health programs that are urgently tackling this problem.

News

24.05.2024

31st Prix Strategis crowns HeroSupport (startupticker.ch)

03.05.2024

USD 6 million to fight a silent epidemic (startupticker.ch)

06.12.2023

Prix Strategis 2024 Semi-finalists unveiled (startupticker.ch)

19.04.2022

Seven Earthshots accelerated from Geneva (startupticker.ch)

13.01.2022

Ten startups to explore Africa (startupticker.ch)

17.06.2021

W. A. de Vigier prize for six startups (startupticker.ch)

Show all

Milestones news

01.06.2023

Completion of lab validation studies

30.04.2023

Completion of 1st stage human factors testing

21.09.2021

Closing of seed round

01.06.2021

Testmate Health kicks off at Biôpole

Show all
Swiss Startup - Testmate Health Product Image Swiss Startup - Testmate Health Team Image Swiss Startup - Testmate Health Additional Image